Tags : Biosimilar Switching Program

Biosimilars

British Columbia Adds Humira Adalimumab to Biosimilar Switching Program

Shots: British Columbia and Health Minister Adrian Dix expand the biosimilar switching program to include Humira adalimumab and a new indication for Enbrel etanercept The expansion of the biosimilar switching program demonstrated the province’s continued confidence in biosimilars to manage costs and fund innovative new therapies while supporting positive patient outcomes BC continues to apply […]Read More